Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk

CONCLUSIONS: These data highlight the role of immune cell regulation in the progression of CH to MN and the promise of leveraging multi-omic characterization of CH to improve MN risk stratification.PMID:38446993 | DOI:10.1158/1078-0432.CCR-23-3468
Source: Clinical Cancer Research - Category: Cancer & Oncology Authors: Source Type: research